|
|
||||||||
Ann Thorac Surg 2000;69:1827-1832
© 2000 The Society of Thoracic Surgeons
a Department of Cardiac Surgery, University of Glasgow, Royal Infirmary, Glasgow, Scotland, United Kingdom
Address reprint requests to Dr Muriithi, Department of Cardiac Surgery, University of Glasgow, Royal Infirmary, 10 Alexandra Parade, Glasgow G31 2ER, Scotland
e-mail: e.w.muriithi{at}clinmed.gla.ac.uk
Background. Cardiopulmonary bypass is associated with impaired platelet macroaggregation. Heparin contributes to platelet dysfunction before extracorporeal circulation. In vitro heparinization of whole blood does not impair macroaggregation. Heparin releases several endothelial proteins; thus heparin may inhibit macroaggregation indirectly.
Methods. Patients undergoing operations using cardiopulmonary bypass and ABO blood group compatible volunteers were studied. Whole blood impedance aggregometry assessed macroaggregation in response to collagen (0.6 µg ml-1) in blood diluted either with normal saline or with platelet poor plasma, obtained from patients at different stages of cardiopulmonary bypass.
Results. Before heparinization, blood diluted with its own platelet poor plasma recorded an impedance change of 13.0 (4.7 to 15.6) Ohms. Platelet poor plasma obtained after heparinization or during extracorporeal circulation reduced this response to 3.7 (1.1 to 8.4) and 2.0 (1.1 to 3.3) Ohms, respectively (both p < 0.0001 versus pre-heparin; n = 13). Macroaggregation in blood from volunteers was similarly inhibited by patients platelet poor plasma (n = 30). The macroaggregatory response in blood sampled after heparinization for cardiopulmonary bypass, decreased gradually from 11.4 (8.2 to 15.9) Ohms immediately after sampling to 1.7 (1.4 to 4.1) Ohms 2 hours later (p < 0.0001; n = 11).
Conclusions. In vivo heparinization induces plasma changes that inhibit platelet macroaggregation. This is an indirect, delayed inhibition that is transferable in vitro to normal platelets.
This article has been cited by other articles:
![]() |
A. Ballotta, H. Z. Saleh, H. W. El Baghdady, M. Gomaa, F. Belloli, H. Kandil, Y. Balbaa, F. Bettini, E. Bossone, L. Menicanti, et al. Comparison of early platelet activation in patients undergoing on-pump versus off-pump coronary artery bypass surgery J. Thorac. Cardiovasc. Surg., July 1, 2007; 134(1): 132 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. B. Mossad, S. Machado, and J. Apostolakis Bleeding following deep hypothermia and circulatory arrest in children. Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2007; 11(1): 34 - 46. [Abstract] [PDF] |
||||
![]() |
A. Kulik, F. D. Rubens, P. S. Wells, C. Kearon, T. G. Mesana, J. van Berkom, and B.-K. Lam Early Postoperative Anticoagulation After Mechanical Valve Replacement: A Systematic Review Ann. Thorac. Surg., February 1, 2006; 81(2): 770 - 781. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Shanmugam Tirofiban and emergency coronary surgery Eur. J. Cardiothorac. Surg., October 1, 2005; 28(4): 546 - 550. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Julian, J. J. Valdunciel, J. A. Sastre, and C. Muriel Aspirin-like defect in platelet secretion on a patient undergoing cardiac valve and coronary graft surgery. Perioperative management Interactive CardioVascular and Thoracic Surgery, March 1, 2004; 3(1): 153 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
F D Rubens and T Mesana The inflammatory response to cardiopulmonary bypass: a therapeutic overview Perfusion, January 1, 2004; 19(1_suppl): S5 - S12. [Abstract] [PDF] |
||||
![]() |
E. W. Muriithi, P. R. Belcher, and V. C. Menys Preoperative platelet inhibition and bleeding after cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(3): 739 - 739. [Full Text] [PDF] |
||||
![]() |
F. D. Rubens and T. Mesana Surface Modified Cardiopulmonary Bypass Circuits: Modifying the Inflammatory Response Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2002; 6(4): 301 - 306. [Abstract] [PDF] |
||||
![]() |
P. R. Belcher, E. W. Muriithi, P. Wajon, and J. Gibson Postoperative Bleeding After Coronary Artery Bypass Surgery with Cardiopulmonary Bypass * Response Anesth. Analg., November 1, 2002; 95(5): 1466 - 1467. [Full Text] [PDF] |
||||
![]() |
Y. Misawa, H. Konishi, and K. Fuse Platelet aggregates and cardiopulmonary bypass Ann. Thorac. Surg., September 1, 2001; 72(3): 981 - 982. [Full Text] [PDF] |
||||
![]() |
E. W. Muriithi and P. R. Belcher Heparin and platelet function Ann. Thorac. Surg., July 1, 2001; 72(1): 320 - 321. [Full Text] [PDF] |
||||
![]() |
S. D. Mentzelopoulos, J. N. Kokotsakis, C. N. Romana, and E. A. Karamichali Intracoronary Thrombolysis and Intraaortic Balloon Counterpulsation for the Emergency Treatment of Probable Coronary Embolism After Repair of an Acute Ascending Aortic Dissection Anesth. Analg., July 1, 2001; 93(1): 56 - 59. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. W. Muriithi, P. R. Belcher, J. N. Rao, M. A. Chaudhry, D. Nicol, and D. J. Wheatley The effects of heparin and extracorporeal circulation on platelet counts and platelet microaggregation during cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., September 1, 2000; 120(3): 538 - 543. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |